Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (221-230 of 367) with videos related to

Pageof 37
Sort By:
Blood|May 25, 2016
FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitorsChristoph J Hofbauer, Sylvia Kepa, Michael Schemper, et al.
Hematology (Amsterdam, Netherlands)|July 5, 2025
A-SURE: intra-patient comparison of prophylactic effectiveness of a recombinant factor VIII Fc fusion protein versus standard half-life factor VIII in hemophilia AJohannes Oldenburg, Charles Hay, Flora Peyvandi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 26, 2026
Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolismTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
Haematologica|March 8, 2005
Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort studyHeinz Gisslinger, Marcus Müllner, Ingrid Pabinger, et al.
Journal of Thrombosis and Haemostasis : JTH|May 16, 2023
Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort studyStephan Nopp, Florian Moik, Simon Kraler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyJonas Ahlbrecht, Boris Dickmann, Cihan Ay, et al.
International Journal of Molecular Sciences|February 25, 2023
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial FibrillationStephan Nopp, M Leontien van der Bent, Daniel Kraemmer, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective studyFlorian Posch, Julia Riedl, Eva-Maria Reitter, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international studySuzanne Murray, Claire McLintock, Patrice Lazure, et al.
Journal of Thrombosis and Haemostasis : JTH|April 20, 2021
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)Johannes Thaler, Cihan Ay, Karoline V Gleixner, et al.
Pageof 37

Showing results (221-230 of 367) with videos related to

Sort By:
Pageof 37
Blood|May 25, 2016
FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitorsChristoph J Hofbauer, Sylvia Kepa, Michael Schemper, et al.
Hematology (Amsterdam, Netherlands)|July 5, 2025
A-SURE: intra-patient comparison of prophylactic effectiveness of a recombinant factor VIII Fc fusion protein versus standard half-life factor VIII in hemophilia AJohannes Oldenburg, Charles Hay, Flora Peyvandi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 26, 2026
Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolismTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
Haematologica|March 8, 2005
Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort studyHeinz Gisslinger, Marcus Müllner, Ingrid Pabinger, et al.
Journal of Thrombosis and Haemostasis : JTH|May 16, 2023
Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort studyStephan Nopp, Florian Moik, Simon Kraler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyJonas Ahlbrecht, Boris Dickmann, Cihan Ay, et al.
International Journal of Molecular Sciences|February 25, 2023
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial FibrillationStephan Nopp, M Leontien van der Bent, Daniel Kraemmer, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective studyFlorian Posch, Julia Riedl, Eva-Maria Reitter, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international studySuzanne Murray, Claire McLintock, Patrice Lazure, et al.
Journal of Thrombosis and Haemostasis : JTH|April 20, 2021
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)Johannes Thaler, Cihan Ay, Karoline V Gleixner, et al.
Pageof 37